Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: J Heart Lung Transplant. 2022 Aug 28;41(12):1808–1818. doi: 10.1016/j.healun.2022.08.019

Table 2:

Hemodynamics at Baseline Visit by Anticoagulation Exposure

Ever Anticoagulation
(n=316)		 No Anticoagulation (n=859) p-value
HR (beats per minute) [n = 812] 78.5 ± 14.7 80.8 ± 16.2 0.065
SBP Pressure (mm Hg) [n = 749] 130.9 ± 24.2 128.2 ± 22.9 0.157
DBP (mm Hg) [n = 745] 77.8 ± 14.2 76.5 ± 13.8 0.243
Pulse Pressure (mm Hg) [n = 1142] 46.0 ± 14.6 46.2 ± 13.7 0.839
RAP (mm Hg) [n = 1125] 9 [5 – 14] 9 [6 – 14] 0.514
Mean PAP (mm Hg) [n = 1146] 48.2 ± 13.2 49.0 ± 13.4 0.333
PAPi [n = 1098] 4.8 [3.1 – 7.8] 5.1 [3.4 – 8.4] 0.234
PVR (Woods Units) [n = 1040] 8.8 [5.8 – 12.8] 9.1 [6.2 – 12.7] 0.379
PAWP (mm Hg) [n = 1109] 11 [8 – 15] 10 [7 – 13] 0.014
RVSWI (g/m/beat/m2) [n = 748] 12.8 [9.9 – 17.0] 13.8 [10.4 – 17.9] 0.019
Cardiac Index (L/min/m2) [n = 1056] 2.1 [1.7 – 2.6] 2.2 [1.8 – 2.7] 0.434
Cardiac Output (L/min) [n = 1085] 4.0 [3.2 – 5.0] 4.1 [3.3 – 5.1] 0.228